S3MartMed – European Strategic Cluster Partnership for investments in smart specializations in the technological area.
A new initiative co-financed under the European Union program – COSME, ESPC for investments in smart specializations.
The project will be implemented in the period from 1 October 2018 to 1 October 2020.
Project partners, 5 clusters:
- Lyonbiopôle (region Auvergne-Rhône-Alpes, Francja),
- Biowin (Walonia, Belgia),
- BioPmed (Piemont, Włochy),
- GAPR – MedSilesia (Górny Śląsk, Polska)
- BioRegio STERN (Badenia Wurtembergia, Niemcy).
From 2017. 24 regions have joined the S3 Industrial Modernization Platform group dealing with medical technologies. As part of the platform’s activities, regional authorities, clusters, and organizations involved in issues related to regional policy and regional development met regularly to exchange experiences, identify cooperation opportunities and joint initiatives that could be supported under regional S3 strategies. Today, the platform helps the ReConfirm consortium to identify future flagship investment projects at the European level.
5 partner clusters, which are part of the S3 platform, have decided to create a new European Strategic Partnership to contribute to the creation of links and closer interregional cooperation, in particular to the intensification of activities undertaken jointly by research and development units and entrepreneurs (SMEs) in terms of future investments and transfer of medical technologies.
The main objective of the S3martMed project is therefore to support interregional and intersectoral cooperation in the field of medical technologies – between European clusters and their members from the SME sector. This is to be achieved primarily by the established cluster partnership, webinars on legal regulations in the med-tech area, matchmaking platform, brokerage meetings, consultancy on financing joint research projects, and creating recommendations for regional policies based on developed cooperation models. All activities within the network will be open activities, open to all regions, clusters, and SMEs involved in the S3Medtech platform.